Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
tak
/
Takeda Pharmaceutical Co Ltd
TAK
Add to Watchlist
16.835
USD
-0.035
-0.21%
Close 07-23 16:00(ET)
Quotes delayed by 15 min
0.000
USD
0.000
Pre-market 07/24, 09:30 (ET)
53.19B
Market Cap
43.89
P/E TTM
Takeda Pharmaceutical Co Ltd
16.835
-0.035
-0.21%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Mon, Apr 6
Updated: Mon, Apr 6
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Capital Research Global Investors
0.43%
Arrowstreet Capital, Limited Partnership
0.18%
Parametric Portfolio Associates LLC
0.17%
D. E. Shaw & Co., L.P.
0.14%
Fidelity Management & Research Company LLC
0.13%
Other
98.95%
Shareholders
Shareholders
Proportion
Capital Research Global Investors
0.43%
Arrowstreet Capital, Limited Partnership
0.18%
Parametric Portfolio Associates LLC
0.17%
D. E. Shaw & Co., L.P.
0.14%
Fidelity Management & Research Company LLC
0.13%
Other
98.95%
Shareholder Types
Shareholders
Proportion
Investment Advisor
1.79%
Investment Advisor/Hedge Fund
0.45%
Hedge Fund
0.33%
Research Firm
0.13%
Individual Investor
0.04%
Family Office
0.02%
Family Office
0.01%
Family Office
0.01%
Other
97.22%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
637
85.31M
2.70%
-8.14M
2025Q4
616
84.00M
2.66%
-4.46M
2025Q3
606
78.67M
2.49%
-1.76M
2025Q2
594
72.78M
2.30%
-6.62M
2025Q1
603
72.05M
2.31%
-7.59M
2024Q4
595
73.56M
2.33%
-9.88M
2024Q3
583
77.60M
2.45%
-3.33M
2024Q2
581
73.43M
2.34%
-14.54M
2024Q1
593
78.98M
2.52%
-11.62M
2023Q4
609
83.80M
2.67%
-18.91M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Capital Research Global Investors
13.49M
0.43%
+82.64K
+0.62%
Dec 31, 2025
Arrowstreet Capital, Limited Partnership
5.68M
0.18%
+2.85M
+100.89%
Dec 31, 2025
Parametric Portfolio Associates LLC
5.52M
0.17%
-529.41K
-8.76%
Dec 31, 2025
D. E. Shaw & Co., L.P.
4.29M
0.14%
+4.01M
+1426.43%
Dec 31, 2025
Fidelity Management & Research Company LLC
4.04M
0.13%
-130.08K
-3.12%
Dec 31, 2025
Brandes Investment Partners, L.P.
3.88M
0.12%
-49.92K
-1.27%
Dec 31, 2025
Goldman Sachs Asset Management, L.P.
3.10M
0.1%
-231.77K
-6.96%
Dec 31, 2025
UBS Financial Services, Inc.
4.09M
0.13%
-1.77M
-30.20%
Dec 31, 2025
Aperio Group, LLC
2.73M
0.09%
-577.00K
-17.45%
Dec 31, 2025
Renaissance Technologies LLC
2.62M
0.08%
-1.25M
-32.25%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
VanEck Pharmaceutical ETF
5.05%
SGI Enhanced Global Income ETF
0.76%
Adasina Social Justice All Cap Global ETF
0.49%
First Trust Value Line Dividend Index Fund
0.38%
ActivePassive International Equity ETF
0.3%
Avantis Responsible International Equity ETF
0.09%
Avantis International Equity ETF
0.05%
Roundhill GLP-1 & Weight Loss ETF
0%
DFA Dimensional International Core Equity 2 ETF
0%
Invesco Zacks Multi-Asset Income ETF
0%
View more
VanEck Pharmaceutical ETF
Proportion
5.05%
SGI Enhanced Global Income ETF
Proportion
0.76%
Adasina Social Justice All Cap Global ETF
Proportion
0.49%
First Trust Value Line Dividend Index Fund
Proportion
0.38%
ActivePassive International Equity ETF
Proportion
0.3%
Avantis Responsible International Equity ETF
Proportion
0.09%
Avantis International Equity ETF
Proportion
0.05%
Roundhill GLP-1 & Weight Loss ETF
Proportion
0%
DFA Dimensional International Core Equity 2 ETF
Proportion
0%
Invesco Zacks Multi-Asset Income ETF
Proportion
0%